Identifying new Risk Markers and Potential Targets for Coronary Artery Disease: The Value of the Lipidome and Metabolome (Q38741609)

6 September 2017

Identifying new Risk Markers and Potential Targets for Coronary Artery Disease: The Value of the Lipidome and Metabolome (English)

1 reference

6 September 2017

coronary artery disease

1 reference

Reijo Laaksonen

1

1 reference

6 September 2017

20 February 2016

1 reference

Cardiovascular Drugs and Therapy

6 September 2017

1 reference

6 September 2017

30

1 reference

6 September 2017

1

1 reference

6 September 2017

19-32

1 reference

Long-term performance and stability of molecular shotgun lipidomic analysis of human plasma samples.

6 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Focused metabolomic profiling in the drug development process: advances from lipid profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

A metabolomic profile is associated with the risk of incident coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited) -- a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Cardiovascular disease risk assessment in older women: can we improve on Framingham? British Women's Heart and Health prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Metabolic profiles predict adverse events after coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Plasma lipid composition and risk of developing cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Plasma lipidomic analysis of stable and unstable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Alteration in metabolic signature and lipid metabolism in patients with angina pectoris and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-016-6651-8

10.1007/S10557-016-6651-8

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference

PubMed ID

26896184